Grace Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2 | -4 | -2 | -2 |
EBITDA | -3,008 | -3,356 | -3,525 | -3,088 |
EBIT | -3,010 | -3,360 | -3,527 | -3,090 |
Net Income | -1,178 | -3,176 | -1,308 | -3,362 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,706 | -2,218 | -3,154 | -1,801 |
Cash | 16,977 | 18,672 | 16,862 | 20,005 |
Basic Shares | 16,510 | 16,933 | 15,924 | 15,924 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -7 | -11 | -124 |
EBITDA | -11,070 | -23,742 | -15,370 | -24,511 |
EBIT | -11,077 | -23,752 | -15,425 | -24,679 |
Net Income | -7,793 | -13,625 | -17,441 | -57,386 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,869 | -14,904 | -12,355 | -15,930 |
Cash | 16,977 | 22,133 | 23,005 | 27,875 |
Basic Shares | 16,510 | 12,087 | 9,529 | 7,435 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.08 |
2025-12-31 | -$0.19 |
2025-09-30 | -$0.08 |
2025-06-30 | -$0.29 |